Literature DB >> 33563334

Alterations of RNA splicing patterns in esophagus squamous cell carcinoma.

Jiyu Ding1,2, Chunquan Li3, Yinwei Cheng1,2, Zepeng Du4, Qiuyu Wang3, Zhidong Tang3, Chao Song3, Qiaoxi Xia1,2, Wenjing Bai1,2, Ling Lin1,2, Wei Liu1,2, Liyan Xu1,5, Enmin Li6,7, Bingli Wu8,9.   

Abstract

Alternative splicing (AS) is an important biological process for regulating the expression of various isoforms from a single gene and thus to promote proteome diversity. In this study, RNA-seq data from 15 pairs of matched esophageal squamous cell carcinoma (ESCC) and normal tissue samples as well as two cell lines were analyzed. AS events with significant differences were identified between ESCC and matched normal tissues, which were re-annotated to find protein coding genes or non-coding RNAs. A total of 45,439 AS events were found. Of these, 6019 (13.25%) significant differentially AS events were identified. Exon skipping (SE) events occupied the largest proportion of abnormal splicing events. Fifteen differential splicing events with the same trends of ΔΨ values in ESCC tissues, as well in the two cell lines were found. Four pathways and 20 biological processes related to pro-metastasis cell junction and migration were significantly enriched for the differentially spliced genes. The upregulated splicing factor SF3B4, which regulates 92 gene splicing events, could be a potential prognostic factor of ESCC. Differentially spliced genes, including HNRNPC, VCL, ZNF207, KIAA1217, TPM1 and CALD1 are shown with a sashimi plot. These results suggest that cell junction- and migration-related biological processes are influenced by AS abnormalities, and aberrant splicing events can be affected by splicing factor expression changes. The involved splicing factor SF3B4 was found to be a survival-related gene in ESCC and is presumed to regulate AS in multiple cancers. In summary, we identified significant differentially expressed AS events which may be related to the development of ESCC.

Entities:  

Keywords:  Alternative splicing; Esophagus squamous cell carcinoma; MISO

Year:  2021        PMID: 33563334     DOI: 10.1186/s13578-021-00546-z

Source DB:  PubMed          Journal:  Cell Biosci        ISSN: 2045-3701            Impact factor:   7.133


  48 in total

1.  Cancer statistics, 2019.

Authors:  Rebecca L Siegel; Kimberly D Miller; Ahmedin Jemal
Journal:  CA Cancer J Clin       Date:  2019-01-08       Impact factor: 508.702

Review 2.  Structural Insights into Nuclear pre-mRNA Splicing in Higher Eukaryotes.

Authors:  Berthold Kastner; Cindy L Will; Holger Stark; Reinhard Lührmann
Journal:  Cold Spring Harb Perspect Biol       Date:  2019-11-01       Impact factor: 10.005

Review 3.  The role of alternative splicing in cancer: From oncogenesis to drug resistance.

Authors:  Rocco Sciarrillo; Anna Wojtuszkiewicz; Yehuda G Assaraf; Gerrit Jansen; Gertjan J L Kaspers; Elisa Giovannetti; Jacqueline Cloos
Journal:  Drug Resist Updat       Date:  2020-09-28       Impact factor: 18.500

4.  Splicing: Going in circles.

Authors:  Eytan Zlotorynski
Journal:  Nat Rev Genet       Date:  2017-12-18       Impact factor: 53.242

Review 5.  RNA mis-splicing in disease.

Authors:  Marina M Scotti; Maurice S Swanson
Journal:  Nat Rev Genet       Date:  2015-11-23       Impact factor: 53.242

Review 6.  Roles and mechanisms of alternative splicing in cancer - implications for care.

Authors:  Sophie C Bonnal; Irene López-Oreja; Juan Valcárcel
Journal:  Nat Rev Clin Oncol       Date:  2020-04-17       Impact factor: 66.675

7.  Comprehensive identification of alternative back-splicing in human tissue transcriptomes.

Authors:  Peng Zhang; Xiao-Ou Zhang; Tingting Jiang; Lingling Cai; Xiao Huang; Qi Liu; Dan Li; Aiping Lu; Yan Liu; Wen Xue; Peng Zhang; Zhiping Weng
Journal:  Nucleic Acids Res       Date:  2020-02-28       Impact factor: 16.971

Review 8.  Oesophageal cancer.

Authors:  Elizabeth C Smyth; Jesper Lagergren; Rebecca C Fitzgerald; Florian Lordick; Manish A Shah; Pernilla Lagergren; David Cunningham
Journal:  Nat Rev Dis Primers       Date:  2017-07-27       Impact factor: 52.329

9.  Identification of novel alternative splicing isoform biomarkers and their association with overall survival in colorectal cancer.

Authors:  Haifeng Lian; Aili Wang; Yuanyuan Shen; Qian Wang; Zhenru Zhou; Ranran Zhang; Kun Li; Chengxia Liu; Hongtao Jia
Journal:  BMC Gastroenterol       Date:  2020-06-05       Impact factor: 3.067

10.  SnapShot: Splicing Alterations in Cancer.

Authors:  Mohammad Alinoor Rahman; Adrian R Krainer; Omar Abdel-Wahab
Journal:  Cell       Date:  2020-01-09       Impact factor: 41.582

View more
  1 in total

1.  Characterizing isoform switching events in esophageal adenocarcinoma.

Authors:  Yun Zhang; Katherine M Weh; Connor L Howard; Jean-Jack Riethoven; Jennifer L Clarke; Kiran H Lagisetty; Jules Lin; Rishindra M Reddy; Andrew C Chang; David G Beer; Laura A Kresty
Journal:  Mol Ther Nucleic Acids       Date:  2022-08-17       Impact factor: 10.183

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.